Variable | Ptreat | Ptime | Zeolite | Placebo | Zeolite | Placebo | Reference range |
---|---|---|---|---|---|---|---|
0 week | 0 week | 12 weeks | 12 weeks | ||||
zonulin | 0.006 | >0.1 | 61.2 ± 11.0 | 56.1 ± 13.2 | 43.8 ± 14.3 | 59.6 ± 12.3 | <55 |
ng . mL-1 | |||||||
α1-antitrypsin | >0.1 | >0.1 | 27.6 ± 14.8 | 32.8 ± 15.6 | 30.2 ± 18.1 | 35.8 ± 17.7 | <37.5 |
mg . dL-1 | |||||||
CP | >0.1 | <0.001 | 218 ± 102 | 206 ± 98 | 508 ± 108 | 486 ± 87 | 80–200 |
pmol . mg-1 | |||||||
iPF2α-III | >0.1 | >0.1 | 216 ± 55 | 200 ± 55 | 199 ± 73 | 181 ± 43 | 50–400 |
pg . mL-1 | |||||||
GPx3 | >0.1 | <0.001 | 131 ± 69 | 107 ± 58 | 182 ± 64 | 193 ± 59 | 33–98 |
IU . L-1 | |||||||
DNA SB | >0.1 | >0.1 | 0.36 ± 0.25 | 0.35 ± 0.24 | 0.49 ± 0.33 | 0.48 ± 0.29 | 0–70 |
AU | |||||||
TNF-α | >0.1 | 0.024 | 26.1 ± 8.7 | 24.3 ± 12.3 | 31.8 ± 11.5 | 28.7 ± 11.8 | 0–69 |
pg . mL-1 | |||||||
IL-6 | >0.1 | >0.1 | 26.6 ± 2.0 | 27.1 ± 1.7 | 27.7 ± 3.2 | 26.9 ± 2.7 | <100 |
pg . mL-1 | |||||||
IL-8 | >0.1 | >0.1 | 38.1 ± 10.8 | 41.9 ± 12.0 | 39.7 ± 11.5 | 39.8 ± 9.7 | 0–62 |
pg . mL-1 | |||||||
IL-10 | 0.087 | >0.1 | 40.1 ± 19.2 | 42.1 ± 16.0 | 54.5 ± 27.8 | 37.9 ± 22.2 | none |
pg . mL-1 | |||||||
IL-22 | >0.1 | >0.1 | 42.9 ± 4.2 | 41.4 ± 3.3 | 40.5 ± 3.3 | 40.1 ± 4.4 | none |
pg . mL-1 |